Experts say that if generic production reduces prices to sustainable levels, large-scale treatment could extend into low- and middle-income countries, much as has occurred with therapies for HIV, tuberculosis, and malaria
District Court, Southern District of Texas Explore Our Practice Areas What Is a Personal Injury
Its little eyes lay flush against beaded, scaly skin
Sometimes, our inventions turn out to be our best science experiments
Practical guardrails If your clients are weighing GLP-1 coverage, here are some of the strategies worth discussing: Conversations to have with clients right now Heres how to frame the discussion with HR and finance leaders: What to watch in 2026 Bottom Line GLP-1s are no longer a side note in benefits discussions
In this way, the deal goes beyond the other agreements President Trump has struck with other pharma companies including Pfizer and AstraZeneca, which experts expect will have little impact on drug affordability